CVS Health Corp. Files 8-K: Officer/Director Changes & Compensation Updates

Ticker: CVS · Form: 8-K · Filed: 2025-04-08T00:00:00.000Z

Sentiment: neutral

Topics: corporate-governance, officer-changes, director-changes, compensation

Related Tickers: CVS

TL;DR

CVS HEALTH Corp filed an 8-K on 4/7/25 for officer/director changes and compensation updates.

AI Summary

On April 7, 2025, CVS Health Corporation filed an 8-K report detailing the departure of certain officers and directors, the election of new directors, and updates to compensatory arrangements. The filing also includes Regulation FD disclosures and financial statements/exhibits.

Why It Matters

Changes in corporate leadership and compensation can signal shifts in company strategy or governance, impacting investor confidence and future performance.

Risk Assessment

Risk Level: low — This filing primarily concerns routine corporate governance updates and does not appear to involve significant financial or operational risks.

Key Players & Entities

FAQ

What specific officer or director positions were affected by the changes reported in the 8-K?

The filing indicates the 'Departure of Directors or Certain Officers' and 'Appointment of Certain Officers,' but does not specify the exact positions in the provided text.

Were there any new directors elected to the CVS Health Corporation board?

Yes, the filing lists 'Election of Directors' as an item information, indicating new directors were elected.

What is the nature of the updates to compensatory arrangements mentioned in the filing?

The filing mentions 'Compensatory Arrangements of Certain Officers,' suggesting changes or new details regarding executive pay, but the specifics are not detailed in this excerpt.

Does the 8-K filing include any financial statements?

Yes, the filing explicitly lists 'Financial Statements and Exhibits' as part of the information provided.

What is the primary purpose of this 8-K filing for CVS Health Corporation?

The primary purpose is to report current information regarding corporate governance changes, including officer and director departures/appointments, and updates to executive compensation, as well as Regulation FD disclosures and financial exhibits.

From the Filing

0001193125-25-075089.txt : 20250408 0001193125-25-075089.hdr.sgml : 20250408 20250408063651 ACCESSION NUMBER: 0001193125-25-075089 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 15 CONFORMED PERIOD OF REPORT: 20250407 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers ITEM INFORMATION: Regulation FD Disclosure ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20250408 DATE AS OF CHANGE: 20250408 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CVS HEALTH Corp CENTRAL INDEX KEY: 0000064803 STANDARD INDUSTRIAL CLASSIFICATION: RETAIL-DRUG STORES AND PROPRIETARY STORES [5912] ORGANIZATION NAME: 07 Trade & Services EIN: 050494040 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-01011 FILM NUMBER: 25820224 BUSINESS ADDRESS: STREET 1: ONE CVS DR. CITY: WOONSOCKET STATE: RI ZIP: 02895 BUSINESS PHONE: 4017651500 MAIL ADDRESS: STREET 1: ONE CVS DR. CITY: WOONSOCKET STATE: RI ZIP: 02895 FORMER COMPANY: FORMER CONFORMED NAME: CVS CAREMARK CORP DATE OF NAME CHANGE: 20070509 FORMER COMPANY: FORMER CONFORMED NAME: CVS/CAREMARK CORP DATE OF NAME CHANGE: 20070322 FORMER COMPANY: FORMER CONFORMED NAME: CVS CORP DATE OF NAME CHANGE: 19970128 8-K 1 d948665d8k.htm 8-K 8-K CVS HEALTH Corp false 0000064803 0000064803 2025-04-07 2025-04-07     UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549     FORM 8-K     CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): April 7, 2025         CVS HEALTH CORPORATION (Exact Name of Registrant as Specified in Charter)       Delaware   001-01011   05-0494040 (State or Other Jurisdiction of Incorporation)   (Commission File Number)   (I.R.S. Employer Identification No.) One CVS Drive Woonsocket , Rhode Island 02895 (Address of Principal Executive Offices, and Zip Code) (401) 765-1500 Registrant’s Telephone Number, Including Area Code N/A (Former name, former address and former fiscal year, if changed since last report)     Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:   ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)   ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)   ☐ Pre-commencement communication pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))   ☐ Pre-commencement communication pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act:   Title of each class   Trading Symbol(s)   Name of each exchange on which registered Common Stock, par value $0.01 per share   CVS   New York Stock Exchange Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR 230.405of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR 240.12b-2 of this chapter). Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐       Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. Appointment of Brian O. Newman as Executive Vice President and Chief Financial Officer On April 7, 2025, the Board of Directors of CVS Health

View on Read The Filing